IL13 and Alzheimer disease: First, we induced a skin barrier defect in human skin explants by repeated tape-stripping, and second, we used an established 3D human skin equivalent where an AD phenotype was induced by treatment with the Th2 cytokines IL-4 and IL-13 (38).